Barclays »

Beam Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Beam Therapeutics (BEAM) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Beam Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Beam Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beam Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.8M 248k 27.22
2023-09-30 $4.8M 198k 24.04
2023-06-30 $4.6M 145k 31.94
2023-03-31 $3.5M 116k 30.64
2022-12-31 $4.8M 122k 39.11
2022-09-30 $5.2M 109k 47.63
2022-06-30 $1.2M 31k 38.63
2022-03-31 $860k 15k 57.20